Author: Teramoto Tamio
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.13, Iss.6, 2012-04, pp. : 859-865
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Switch to rosuvastatin leads to greater LDL-C reduction
Inpharma, Vol. 1, Iss. 1436, 2004-01 ,pp. :
HDL-C predictive of CV events in statin users
Inpharma, Vol. 1, Iss. 1609, 2007-01 ,pp. :
New Drugs for HDL-C Disorders: The Beginning
Current Medicinal Chemistry, Vol. 21, Iss. 25, 2014-08 ,pp. :